These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32885514)

  • 1. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Aspergillus galactomannan Ag VIRCLIA® Monotest and the sõna Aspergillus galactomannan lateral flow assay show comparable performance for the diagnosis of invasive aspergillosis.
    Küpper C; Erb TM; Träger J; Meintker L; Valenza G; Bogdan C; Held J
    Mycoses; 2024 Aug; 67(8):e13782. PubMed ID: 39109555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
    Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
    Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar lavage fluid IMMY Sona Aspergillus lateral-flow assay for the diagnosis of invasive pulmonary aspergillosis: a prospective, real life evaluation.
    Arkell P; Mahboobani S; Wilson R; Fatania N; Coleman M; Borman AM; Johnson EM; Armstrong-James DPH; Abdolrasouli A
    Med Mycol; 2021 Apr; 59(4):404-408. PubMed ID: 33479770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.
    Jenks JD; Mehta SR; Taplitz R; Aslam S; Reed SL; Hoenigl M
    Mycoses; 2019 Mar; 62(3):230-236. PubMed ID: 30565352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different lateral flow assays on bronchoalveolar lavage fluid for invasive aspergillosis screening in non-hematological patients.
    Devillers E; Scherer E; Navellou JC; Grenouillet F; Millon L; Bellanger AP
    J Mycol Med; 2024 Jun; 34(2):101481. PubMed ID: 38718721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study.
    Mercier T; Dunbar A; de Kort E; Schauwvlieghe A; Reynders M; Guldentops E; Blijlevens NMA; Vonk AG; Rijnders B; Verweij PE; Lagrou K; Maertens J
    Med Mycol; 2020 Jun; 58(4):444-452. PubMed ID: 31290552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
    Thornton C; Johnson G; Agrawal S
    J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative performance of the Platelia
    Albert E; Alcaraz MJ; Giménez E; Clari MÁ; Torres I; Colomina J; Olea B; Tormo M; Piñana JL; Oltra R; Signes-Costa J; Carbonell N; Solano C; Navarro D
    Microbiol Spectr; 2024 Aug; 12(8):e0391023. PubMed ID: 38916338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
    Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
    Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.